SCHEMBL112392

SCHEMBL112392

[CH]1C=CC=C2C=CC=CC=C12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL126608 0.87
SCHEMBL29930619 0.87
SCHEMBL30629015 0.87
SCHEMBL28170742 0.87
SCHEMBL11086015 0.83
SCHEMBL27706047 0.83
Bicarbonate SCHEMBL7645241 0.73
SCHEMBL26292 0.71
SCHEMBL3144339 0.71
Naphthalene SCHEMBL27313516 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1521 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6432995-B1 None US claimed
CN-117304161-A Triarylamine compound and organic electroluminescent device thereof 长春海谱润斯科技股份有限公司 2023-12-29 CN claimed
EP-4209492-A1 COMPOUND FOR TREATING THROMBOTIC DISEASES Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2023-07-12 EP claimed
EP-4106872-A1 COMPOSITIONS AND METHODS FOR ASSESSING THE EFFICACY OF INHIBITORS OF NEUROTRANSMITTER TRANSPORTERS Denovo Biopharma LLC (US) 2022-12-28 EP claimed
CN-115515680-A Compositions and methods for assessing efficacy of neurotransmitter transporter inhibitors 索元生物医药有限公司 2022-12-23 CN claimed
CN-115084414-A Organic electroluminescent device 长春海谱润斯科技股份有限公司 2022-09-20 CN claimed
CN-115050900-A Organic electroluminescent device 长春海谱润斯科技股份有限公司 2022-09-13 CN claimed
CN-115050915-A Organic electroluminescent device 长春海谱润斯科技股份有限公司 2022-09-13 CN claimed
CN-114621181-A Star-shaped tetramine derivative and organic electroluminescent device thereof 长春海谱润斯科技股份有限公司 2022-06-14 CN claimed
CN-113968855-A Compound for treating thrombotic diseases 中国科学院上海药物研究所 2022-01-25 CN claimed
US-6080763-A INHIBIT THE RELEASE OF INFLAMMATORY CYTOKINES, E.G., TUMOR NECROSIS FACTOR AND INTERLEUKIN-1; USEFUL TO TREAT CHRONIC INFLAMMATORY DISEASE; AUTOIMMUNE DISEASES, E.G. RHEUMATOID ARTHRITIS, OSTEOPOROSIS; PYRAZOLYLUREAS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2000-06-27 US claimed
WO-1999031087-A1 CYCLIC IMIDE-SUBSTITUTED PYRIDYLALKANE, ALKENE AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS KLINGE PHARMA GMBH (DE) 1999-06-24 WO claimed
WO-1999023091-A1 AROMATIC HETEROCYCLIC COMPOUNDS AS ANTI-INFLAMMATORY AGENTS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1999-05-14 WO claimed
EP-0825988-A1 FUNGICIDAL CYCLIC AMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1998-03-04 EP claimed
WO-1996036616-A1 FUNGICIDAL CYCLIC AMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1996-11-21 WO claimed
EP-0689435-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1996-01-03 EP claimed
WO-1994021248-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1994-09-29 WO claimed
EP-0284359-B1 1,4-DISUBSTITUTED PIPERAZINE COMPOUNDS, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1992-01-08 EP claimed
US-4997836-A Inhibitor of platelet activating factor TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1991-03-05 US claimed
US-4880809-A HYPOTENSIVE AGENTS, AMIDE DERIVATIVES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1989-11-14 US claimed